Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
CORT	Corcept Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$761.41M	$99.65M	13.1%	15.4%	12.8%	$0.82
COLL	Collegium Pharmaceutical, Inc Manufacturing · Year ended 2025-12-31 · USD	$780.57M	$62.87M	8.1%	20.8%	23.6%	$1.73
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
COCP	Cocrystal Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.83M	n/a	-139.5%	n/a	-$0.78
CNTX	Context Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$36.12M	n/a	-59.7%	n/a	-$0.38
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
CNSP	CNS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.85M	n/a	-350.5%	n/a	-$35.75
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
CMPS	COMPASS Pathways plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$287.86M	n/a	n/a	n/a	-$3.08
CMMB	Chemomab Therapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.99M	n/a	-72.9%	n/a	$0.018
CLYM	Climb Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.85M	n/a	-37.3%	n/a	-$0.88
CLRB	Cellectar Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.79M	n/a	-255.2%	n/a	-$8.35
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
CING	Cingulate Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.45M	n/a	-894.8%	n/a	-$4.44
CELU	Celularity Inc Manufacturing · Year ended 2025-12-31 · USD	$26.55M	-$91.72M	-345.4%	n/a	-51.0%	-$3.59
CDT	CDT Equity Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$1177.89
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
CATX	Perspective Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.12M	n/a	-49.8%	n/a	-$1.40
CASIF	CASI Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.71M	-$48.06M	-232.0%	n/a	-27.4%	-$2.59
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
CANF	Can-Fite BioPharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$405.0K	-$9.83M	n/m	-175.8%	-39.9%	-$5.97
CAMP	Camp4 Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.50M	-$80.40M	n/m	-168.5%	436.5%	-$2.65
CALC	CalciMedica, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.56M	n/a	n/a	n/a	-$1.97
BYSI	BeyondSpring Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.01M	n/a	n/a	n/a	n/a

Rows per page: 2550 100